Ankara - The Iranian Razi Institute has signed a memorandum of understanding (MoU) with a Turkish company to facilitate joint ventures in producing raw materials and exporting biological products.
 
The MoU was signed in Ankara during the 8th meeting of the Iran-Turkey Strategic Committee attended by Iranian Agriculture Minister Gholamreza Nouri, Iranian Ambassador to Turkey Mohammad Hassan Habibollahzadeh, and senior Iranian and Turkish officials and entrepreneurs.  
 
On the sidelines of the signing ceremony, the Iranian minister hailed the efforts made by the prestigious institute and called for further international support, particularly from the Ministry of Foreign Affairs, to pave the way for the institute's access to global markets.
 
Rainak Ghaderi, Head of the Razi Institute's Department of Scientific Relations and International Cooperation, described the cooperation document as an “achievement”, adding that the partnership will encompass joint research and development initiatives, secure the supply of essential raw materials and antigens, and actively pursue the acquisition of GMP and ISO certifications.  


Iran’s Razi Institute stands at the forefront of vaccine development, playing a crucial role in public health. From eradicating poliomyelitis to pioneering the world's first injectable-inhalable COVID-19 vaccine, its contributions significantly impact both human and animal health.